Skip to content
healthcare.dev
Get a free key

Orladeyo

NDC 72769-112, Berotralstat hydrochloride, pellet, from BioCryst Pharmaceuticals, Inc..

Product NDC
72769-112
Status
Listed
Labeler
BioCryst Pharmaceuticals, Inc.
Dosage form
PELLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219776
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72769-112 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BEROTRALSTAT HYDROCHLORIDE96 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Kallikrein Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; Plasma Kallikrein Inhibitor [EPC]

Package NDCNDC-11Package
72769-112-02727690112024 DOSE PACK in 1 CARTON (72769-112-02) / 7 PACKET in 1 DOSE PACK / 16 PELLET in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3527ece1-e7e0-40b1-b0c5-6baeb0deabeb

Use it

Look up 72769-112 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72769-112 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72769-112. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.